PEA technology is an advanced biochemical method that effectively combines the specificity of antibodies with the sensitivity and amplification power of PCR. At the heart of PEA is a mechanism involving two proximity probes, each made up of an antibody attached to a unique DNA oligonucleotide.
When these probes bind to their target protein, they come close together, allowing the DNA oligonucleotides to hybridize and form a double-stranded DNA molecule. This DNA molecule can then be extended by DNA polymerase.
To enable sample multiplexing, unique sample indices are added during a subsequent PCR step. This leads to the creation of a unique DNA sequence that is directly quantifiable using real-time PCR or Next-Generation Sequencing (NGS), translating the protein’s presence into a measurable DNA signal. The NGS counts obtained are proportional to the protein’s concentration in the sample, allowing for its relative quantification.